awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33871321-F7DB87B5-6F99-4A63-874B-8901CBF1C332
Q33871321-F7DB87B5-6F99-4A63-874B-8901CBF1C332
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33871321-F7DB87B5-6F99-4A63-874B-8901CBF1C332
Metabolic and hemodynamic effects of sodium-dependent glucose cotransporter 2 inhibitors on cardio-renal protection in the treatment of patients with type 2 diabetes mellitus
P2860
Q33871321-F7DB87B5-6F99-4A63-874B-8901CBF1C332
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33871321-F7DB87B5-6F99-4A63-874B-8901CBF1C332
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
57129850194db717ffb9c8df2d66006060290372
P2860
Randomized, placebo-controlled, double-blind glycemic control trial of novel sodium-dependent glucose cotransporter 2 inhibitor ipragliflozin in Japanese patients with type 2 diabetes mellitus